Welcome Dr. Ruffo
OCFM
OCTOBER 23, 2020
October 23, 2020 / Jack Forbush, DO / News Jack Forbush, DO Helpful video out together by one. Notice of Privacy Policy
OCFM
OCTOBER 23, 2020
October 23, 2020 / Jack Forbush, DO / News Jack Forbush, DO Helpful video out together by one. Notice of Privacy Policy
FDA Law Blog
NOVEMBER 26, 2024
By Larry K. Houck — Last May the Department of Justice (“DOJ”) and the Drug Enforcement Administration (“DEA”) issued a Notice of Proposed Rulemaking (“NPRM”) to transfer marijuana from schedule I of the Controlled Substances Act (“CSA”) to schedule III. Schedules of Controlled Substances: Rescheduling of Marijuana, 89 Fed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
FEBRUARY 19, 2024
Prior to entering the legal field, she served as a biomedical/electrical engineer at an engineering firm involved in the design and development of radio frequency (RF) distribution systems from initial market and data preparation through testing and troubleshooting of these products. Gibbs , HP&M Director.
FDA Law Blog
FEBRUARY 9, 2024
We previously blogged on the draft guidance ( here ) and on FDA’s broader framework for Digital Health Technologies (DHT) ( here and here ). A DHT is a system that uses computing platforms, connectivity, software, and/or sensors, for health care and related uses.
FDA Law Blog
JANUARY 4, 2023
Brevig, Senior Regulatory Device and Biologics Expert — On December 7, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to cell therapy and tissue-engineered products chemistry, manufacturing, and controls (CMC).
The Clinical Problem Solvers
SEPTEMBER 30, 2020
Blog post – by Smitha Download CPSolvers App here Patreon website Melanie Fellay Melanie Fellay is the CEO and Co-Founder of Spekit, the leading in-app learning and digital enablement companion that helps employees learn their tools and navigate process changes by accessing training resources in real-time, everywhere they work.
FDA Law Blog
DECEMBER 8, 2022
labeling of major food allergens in bulk foods, dietary supplements, protein-free ingredients, and foods produced through genetic engineering); and. 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g., Other technical labeling matters. 1, 2023, sesame.
Let's personalize your content